Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Buprenorphine Transdermal Delivery System in Subjects With Moderate to Severe Low Back Pain.
This study has been terminated.
First Received: April 10, 2006   Last Updated: April 29, 2006   History of Changes
Sponsor: Purdue Pharma LP
Information provided by: Purdue Pharma LP
ClinicalTrials.gov Identifier: NCT00313014
  Purpose

The objective of this study is to demonstrate the effectiveness and tolerability of the buprenorphine transdermal system (20mg) in comparison to the buprenorphine transdermal system (5mg) and oxycodone immediate release in subjects with moderate to severe low back pain currently treated with oral opioids. The double-blind treatment intervention duration is 12 weeks during which time supplemental analgesic medication (acetaminophen, ibuprofen) will be provided to all subjects in addition to study drug.


Condition Intervention Phase
Chronic Low Back Pain
Drug: Buprenorphine transdermal delivery system
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title: A Multicenter, Randomized, Double-Blind, Active Comparator Study to Determine the Efficacy and Safety of BTDS 20 or OxyIR Versus BTDS 5 in Subjects With Moderate to Severe Low Back Pain

Resource links provided by NLM:


Further study details as provided by Purdue Pharma LP:

Primary Outcome Measures:
  • Average pain over the last 24 hours score at Weeks 4, 8, and 12.

Secondary Outcome Measures:
  • The daily number of tablets of supplemental analgesic medications
  • Oswestry Disability Index scores
  • Medical Outcome Study Sleep Scale scores.

Estimated Enrollment: 891
Study Start Date: February 2004
Estimated Study Completion Date: September 2005
Detailed Description:

Buprenorphine is a synthetic opioid analgesic with over twenty-five years of international clinical experience indicating it to be safe and effective in a variety of therapeutic situations for the relief of moderate to severe pain. Transdermal systems may offer advantages over currently indicated oral products including ease and convenience of use, improved compliance, possible reduction in patient care, and prolonged and consistent delivery of drug.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • low back pain for 3 months or longer, confirmed by radiographic evidence.
  • receiving a stable dose of an opioid analgesic for low back pain.

Exclusion Criteria:

  • taking more than 80 mg per day of oral morphine sulfate or equivalent within 30 days of enrollment.
  • requiring frequent analgesic therapy for chronic condition(s), in addition to low back pain.

Other protocol-specific exclusion/inclusion criteria may apply.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00313014

  Hide Study Locations
Locations
United States, Alabama
Birmingham Pain Center
Birmingham, Alabama, United States, 35244
Winston Physician Services, LLC
Haleyville, Alabama, United States, 35565
Arthritis Clinical Intervention Program
Birmingham, Alabama, United States, 35249
United States, Arizona
Arizona Research Center, Inc.
Phoenix, Arizona, United States, 85023
Radiant Research
Phoenix, Arizona, United States, 85029
Advanced Clinical Therapeutics
Tuscon, Arizona, United States, 85712
United States, Arkansas
Hot Springs Pain Clinic
Hot Springs, Arkansas, United States, 71913
United States, California
Shreenath Clinical Service
Fountain Valley, California, United States, 92708
NuLife Clinical Research, Inc.
Anaheim, California, United States, 92805
International Clinical Research Network
Chula Vista, California, United States, 91911
Accelovance
San Diego, California, United States, 92108
Lovelace Scientific Resources, Inc.
Beverly Hills, California, United States, 90211
U of Calif at Davis, Med Ctr, Pain Management Center
Sacramento, California, United States, 95817
Northern California Research Corp
Carmichael, California, United States, 95608
United States, Colorado
Southern Colorado Clinic
Pueblo, Colorado, United States, 81008
United States, Florida
Renstar Medical
Ocala, Florida, United States, 34471
University Clinical Research, Inc.
Deland, Florida, United States, 32720
Gold Coast Research, LLC
Plantation, Florida, United States, 33324
The Arthritis Center
Palm Harbor, Florida, United States, 34684
Palm Beach Research Center
West Palm Beach, Florida, United States, 33409
University Clinical Research, Inc.
Pembroke Pines, Florida, United States, 33024
Drug Study Institute
Jupiter, Florida, United States, 33458
Peninsula Research Inc.
Ormond Beach, Florida, United States, 32174
Innovative Research of West Florida, Inc.
Largo, Florida, United States, 33770
Chiefland Medical Center
Chiefland, Florida, United States, 32626
Coastal Medical Research
Port Orange, Florida, United States, 32168
United States, Georgia
Georgia Medical Research Institute
Marietta, Georgia, United States, 30060
Atlanta Knee & Shoulder Clinic
Stockbridge, Georgia, United States, 30281
United States, Idaho
Pain Care Boise
Boise, Idaho, United States, 83702
Idaho Arthritis and Osteoporosis Center
Meridian, Idaho, United States, 83742
United States, Illinois
Pain and Rehabilitation Clinic of Chicago
Chicago, Illinois, United States, 60610
United States, Indiana
MediSphere Medical Research Center, LLC
Evansville, Indiana, United States, 47714
GFI Research Center
Evansville, Indiana, United States, 47714
United States, Iowa
Medical Associates Clinics
Dubuque, Iowa, United States, 52002
United States, Kansas
Vince and Associates Clinical Research
Overland Park, Kansas, United States, 66211
CTT, Inc.
Prairie Village, Kansas, United States, 66206
United States, Kentucky
Commonwealth Biomedical Research, LLC
Madisonville, Kentucky, United States, 42431
United States, Louisiana
Louisiana Research Associates, Inc.
New Orleans, Louisiana, United States, 70114
New Orleans Clinical Trial Management Inc.
Metairie, Louisiana, United States, 70006
Research Center of Louisiana
New Orleans, Louisiana, United States, 70115
Best Clinical Trials, LLC
New Orleans, Louisiana, United States, 70115
United States, Maryland
Sinai Hospital of Baltimore
Baltimore, Maryland, United States, 21215
United States, Massachusetts
Future Care Studies
Springfield, Massachusetts, United States, 11070
United States, Michigan
Lake Michigan Clinical Research & Consulting, Inc.
Saint Joseph, Michigan, United States, 49085
Rheumatology PC
Kalamazoo, Michigan, United States, 49009
United States, Missouri
HealthCare Research
St Louis, Missouri, United States, 63141
Medex Healthcare Research, Inc.
St Louis, Missouri, United States, 63108
United States, Nebraska
Meridian Clinical Research, LLC
Omaha, Nebraska, United States, 68134
United States, Nevada
Lovelace Scientific Resources
Henderson, Nevada, United States, 89014
Pivotal Research Centers
North Las Vegas, Nevada, United States, 89030
United States, New York
Research Across America
New York, New York, United States, 10022
United States, North Carolina
MedArk Clinical Research
Morgantown, North Carolina, United States, 28655
Wake Research Associates, LLC
Raleigh, North Carolina, United States, 27612
Triangle Orthopaedic Associates
Durham, North Carolina, United States, 27704
Pharmquest
Greensboro, North Carolina, United States, 27401
Metrolina Medical Research
Charlotte, North Carolina, United States, 28209
Center for Clinical Research
Winston Salem, North Carolina, United States, 27103
Pain and Orthopedic Neurology , Charlotte Spine Center,
Charlotte, North Carolina, United States, 28207
United States, North Dakota
Odyssey Research
Bismark, North Dakota, United States, 58502
United States, Oklahoma
COR Clinical Research, LLC
Oklahoma City, Oklahoma, United States, 73103
Associated Medical Services
Oklahoma City, Oklahoma, United States, 73112
United States, Pennsylvania
Keystone Clinical Research
Altoona, Pennsylvania, United States, 16602
University Orthopedics Center
State College, Pennsylvania, United States, 16801
Central Pennsylvania Clinical Research
Mechanicsburg, Pennsylvania, United States, 17055
Valley Pain Specialists
Bethlehem, Pennsylvania, United States, 18016
Altoona Center for Clinical Research
Duncansville, Pennsylvania, United States, 16635
BioMedical Research Associates
Shippensburg, Pennsylvania, United States, 17257
United States, Rhode Island
Omega Medical Research
Warwick, Rhode Island, United States, 28860
New England Center Clinical Research
Cranston, Rhode Island, United States, 29200
United States, South Carolina
Arthritis & Osteoporosis Center
Orangeburg, South Carolina, United States, 29118
United States, South Dakota
Brown Clinic
Watertown, South Dakota, United States, 57201
United States, Tennessee
Holston Medical Group
Kingsport, Tennessee, United States, 37660
Tri Cities Medical Research
Bristol, Tennessee, United States, 37620
Holston Medical Group
Bristol, Tennessee, United States, 37620
United States, Texas
N. Texas Neuro Research
Wichita Falls, Texas, United States, 76301
Galenos Research
Dallas, Texas, United States, 75251
Clinical Trial Network Oaks Medical Center
Spring, Texas, United States, 77386
Unlimited Research
San Antonio, Texas, United States, 78233
Benchmark Research
San Angelo, Texas, United States, 76904
KRK Medical Research
Richardson, Texas, United States, 75080
Texas Medical Research Associates
San Antonio, Texas, United States, 78238
Team Research of Central Texas
Harker Heights, Texas, United States, 76548
Benchmark Research
Fort Worth, Texas, United States, 76135
United States, Utah
Lifetree Clinical Research
Salt Lake City, Utah, United States, 84106
United States, Wisconsin
Dean Medical Center
Oregon, Wisconsin, United States, 53575
Sponsors and Collaborators
Purdue Pharma LP
  More Information

No publications provided

Study ID Numbers: BUP3015
Study First Received: April 10, 2006
Last Updated: April 29, 2006
ClinicalTrials.gov Identifier: NCT00313014     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by Purdue Pharma LP:
Low back pain
opioid
transdermal

Additional relevant MeSH terms:
Narcotic Antagonists
Nervous System Diseases
Physiological Effects of Drugs
Central Nervous System Depressants
Low Back Pain
Narcotics
Pain
Back Pain
Pharmacologic Actions
Signs and Symptoms
Buprenorphine
Sensory System Agents
Therapeutic Uses
Neurologic Manifestations
Analgesics
Peripheral Nervous System Agents
Central Nervous System Agents
Analgesics, Opioid

ClinicalTrials.gov processed this record on November 25, 2009